Skip to main content
. Author manuscript; available in PMC: 2017 Jul 1.
Published in final edited form as: J Am Coll Surg. 2016 Jan 18;223(1):99–108. doi: 10.1016/j.jamcollsurg.2015.12.057

Table 4. Risk Factors for Major Complications with 2-Stage Hepatectomy.

Risk factor Univariate p value Multivariate*
Odds ratio 95% Confidence interval p Value
Lower Upper
Rectal primary tumor 0.052 3.904 1.248 12.211 0.019
Primary tumor nodal status positive 0.347
Synchronous presentation of CLM 0.081 0.295 0.091 0.953 0.041
> 5 CLM 0.295
Diameter of largest metastasis > 5 cm 0.701
> 6 cycles of chemotherapy before first-stage resection 0.9
Bevacizumab before first-stage resection 0.468
Interval chemotherapy after first-stage resection 0.875
Combined primary surgery at first-stage resection 0.763
Portal vein embolization 0.474
> 1 lesion resected during first-stage resection 0.028 3.594 1.313 9.842 0.013
> 1 lesion resected during second-stage resection 0.225
RAS mutation 0.308
*

Binary logistic regression, using enter method with 0.1 selection.

Based on computed tomography before chemotherapy.

CLM, colorectal liver metastases.